infectious diseases
Overview of Viral Respiratory Infections
Treatment of Viral Respiratory Infections
Supportive Sometimes antiviral drugs Treatment of viral respiratory infections is usually supportive. Antibacterial drugs are ineffective against viral pathogens, and prophylaxis against secondary bacterial infections is not recommended. Antibiotics should be given only when secondary bacterial infections develop. In patients with chronic lung disease, antibiotics may be given with less restriction. 18 years with a suspected viral respiratory tract infection, because Reye Syndrome is a risk. Some patients continue to cough for weeks after resolution of an upper respiratory infection; these symptoms may lessen with use of an inhaled bronchodilator or corticosteroids. In some cases, antiviral drugs are useful: Oseltamivirandzanamivirare effective for influenza. Ribavirin, a guanosine analog that inhibits replication of many RNA and DNA viruses, may be considered for severely immunocompromised patients with lower respiratory tract infection due to RSV. are monoclonal antibodies used to Prevention in infants and young children. ( Nirmatrelvir withritonavir,remdesivir,molnupiravir, or monoclonal antibodies after onset of symptoms of COVID-19 may be considered to prevent progression to severe disease in high-risk patients, andremdesivirand monoclonal antibodies may be considered for severe COVID-19. 